| 20 Août 2014
Overall,  lung cancer rates are declining in the United States, but little is  known about trends related to different subtypes of lung cancer and  different demographic groups. To investigate, Denise Riedel Lewis, PhD,  MPH, of the National Cancer Institute, and her colleagues analyzed  information from the Surveillance, Epidemiology, and End Results (SEER)  program. Their goal was to update the classification of lung cancer  subtypes and to determine the rates of lung cancer overall as well as  the rates of squamous cell, small cell, adenocarcinoma, large cell,  other, and unspecified carcinomas among US whites and blacks diagnosed  from 1977 to 2010 and white non-Hispanics, Asian/Pacific Islanders, and  white Hispanics diagnosed from 1992 to 2010. The  researchers found that squamous and small cell carcinoma rates declined  since the 1990s, although less rapidly among females than males. Rates  for unspecified lung cancer also declined. Adenocarcinoma rates  decreased among males through 2005, after which they rose rapidly from  2006 to 2010 among every racial/ethnic/gender group. Recent  adenocarcinoma rates were higher among young females than among males  for all racial/ethnic groups. The  findings indicate that lung cancer rates vary by subtype, sex,  race/ethnicity, and age. “It is important to monitor these changes as  clinical cancer experts diagnose lung cancer and offer treatment based  on specific characteristics of the cancer,” said Dr. Lewis. Because 90  to 95 percent of lung cancers in the United States are attributable to  smoking, rate changes reflect historical cigarette smoking rates,  duration, cessation, and cigarette composition. “These results can serve  as a place marker for our population’s changing lung exposures,” Dr.  Lewis noted.
A  new analysis confirms that U.S. lung cancer rates are declining  overall, but it also uncovers previously unrecognized trends related to  cancer subtype, sex, race/ethnicity, and age. Published early online in CANCER,  a peer-reviewed journal of the American Cancer Society, the findings  provide a more accurate picture of the state of lung cancer in the  country and will help researchers in their ongoing efforts to monitor  the population’s lung health.









